Cleveland Clinic’s ‘Top 10’ Picks For 2013 Include Eight Device-Related Innovations
This article was originally published in The Gray Sheet
Renowned academic medical center unveils its annual ‘top 10’ list of medical innovations it anticipates will have a major impact on patient care within the next year, including eight that are device-related.
You may also be interested in...
Oslo breast cancer detection study is good news for Hologic. Abbott's bioresorbable stent trial gets under way. More research briefs.
At 15 years of follow-up in the Swedish Obese Subjects study, 110 bariatric surgery patients had developed type 2 diabetes versus 392 non-surgery patients in the control group, corresponding to incidence rates of 6.8 cases and 28.4 cases per 1,000 person-years, respectively.
The findings come from two studies, including the randomized STAMPEDE trial, funded by Johnson & Johnson and the National Institutes of Health, comparing medical therapy with two forms of surgical treatment – gastric bypass or sleeve gastrectomy.